[1] |
Ebata T,Yokoyama Y,Igami T,et al. Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin[J]. J Hepatobiliary Pancreat Sci,2014,21(8):550-555.
|
[2] |
Nagino M. Fifty-year history of biliary surgery[J]. Ann Gastroenterol Surg,2019,3(6):598-605.
|
[3] |
Capobianco I,Rolinger J,Nadalin S. Resection for Klatskin tumors:technical complexities and results[J]. Transl Gastroenterol Hepatol,2018,3: 69.
|
[4] |
Feo CF,Ginesu GC,Barmina M,et al. Curative resection for hilar cholangiocarcinoma: single-center experience with long-term followup[J]. Am Surg,2018,84(1):9-10.
|
[5] |
Kaneoka Y,Yamaguchi A,Isogai M,et al. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy[J]. World J Surg,2010,34(11):2662-2670.
|
[6] |
Fernandes EDES,Mello FT,Ribeiro-Filho J,et al. The largest western experience with hepatopancreatoduodenectomy: lessons learned with 35 cases[J]. Braz Arch Dig Surg,2016,29(1):17-20.
|
[7] |
Welch JC,Gleeson EM,Karachristos A,et al.Hepatopancreatoduodenectomy in North America: are the outcomes acceptable?[J]. HPB,2020,22(3):360-367.
|
[8] |
D'Souza MA,Valdimarsson VT,Campagnaro T,et al.Hepatopancreatoduodenectomy-a controversial treatment for bile duct and gallbladder cancer from a European perspective[J]. HPB,2020,22(9):1339-1348.
|
[9] |
Liu F,Hu HJ,Ma WJ,et al. Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma?[J]. ANZ J Surg,2020,90(9):1666-1670.
|
[10] |
Zhou Y,Zhang Z,Wu L,et al. A systematic review of safety and efficacy of hepatopancreatoduodenectomy for biliary and gallbladder cancers[J]. HPB,2016,18(1):1-6.
|
[11] |
Iacono C,de Bellis M,Guglielmi A. ASO author reflections:hepatopancreatoduodenectomy: why,when,and how?[J]. Ann Surg Oncol,2020,27(9):3358-3359.
|
[12] |
Dai WC,Chok KS,Cheung TT,et al. Hepatopancreatoduodenectomy for advanced hepatobiliary malignancies: a single-center experience[J]. Hepatobiliary Pancreat Dis Int,2017,16(4):382-386.
|
[13] |
Utsumi M,Sadamori H,Shinoura S,et al. Risk factors of morbidity and predictors of long-term survival after hepatopancreatoduodenectomy for biliary cancer[J]. Hepatogastroenterology,2014,61(136):2167-2172.
|
[14] |
Fukami Y,Kaneoka Y,Maeda A,et al. Major hepatopancreatoduodenectomy with simultaneous resection of the hepatic artery for advanced biliary cancer[J]. Langenbecks Arch Surg,2016,401(4):471-478.
|
[15] |
Ishii T,Seo S,Ito T,et al. Liver transection-first approach in hepatopancreatoduodenectomy for hilar cholangiocarcinoma: a safe and secure technique for the early assessment of curable resection and vascular reconstruction[J]. Ann Surg Oncol,2021,28(6):2988-2989.
|
[16] |
Hemming AW. Hepatopancreatoduodenectomy in North America:acceptable outcomes?[J]. HPB,2020,22(3):358-359.
|
[17] |
Aoki T,Sakamoto Y,Kohno Y,et al. Hepatopancreaticoduodenectomy for biliary cancer: strategies for near-zero operative mortality and acceptable long-term outcome[J]. Ann Surg,2018,267(2):332-337.
|
[18] |
Otsubo T,Kobayashi S,Sano K,et al. Safety-related outcomes of the Japanese Society of Hepato-Biliary-Pancreatic Surgery board certification system for expert surgeons[J]. J Hepatobiliary Pancreat Sci,2017,24(5):252-261.
|
[19] |
Ebata T,Yokoyama Y,Igami T,et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients[J]. Ann Surg,2012,256(2):297-305.
|
[20] |
Nagaraj K,Goto Y,Kojima S,et al. Central hepatopancreatoduodenectomy-oncological effectiveness and parenchymal sparing option for diffusely spreading bile duct cancer:report of two cases[J]. BMC Surg,2021,21(1):23.
|
[21] |
Shimizu A,Motoyama H,Kubota K,et al. Safety and oncological benefit of hepatopancreatoduodenectomy for advanced extrahepatic cholangiocarcinoma with horizontal tumor spread: shinshu university experience[J]. Ann Surg Oncol,2021,28(4):2012-2025.
|
[22] |
Mizuno T,Ebata T,Nagino M. Advanced hilar cholangiocarcinoma:an aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: perioperative management,extended procedures,and multidisciplinary approaches[J]. Surg Oncol,2020,33:201-206.
|
[23] |
Nigri GR,Rosman AS,Petrucciani N,et al. Metaanalysis of trials comparing minimally invasive and open distal pancreatectomies[J].Surg Endosc,2011,25(5):1642-1651.
|
[24] |
Zhou Y,Yang C,Wang S,et al. Does external pancreatic duct stent decrease pancreatic fistula rate after pancreatic resection?: a metaanalysis[J]. Pancreatology,2011,11(3):362-370.
|
[25] |
Miwa S,Kobayashi A,Akahane Y,et al. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?[J]. J Hepatobiliary Pancreat Surg,2007,14(2):136-141.
|
[26] |
Yamamoto Y,Sugiura T,Okamura Y,et al. Is combined pancreatoduodenectomy for advanced gallbladder cancer justified?[J]. Surgery,2016,159(3):810-820.
|
[27] |
Sakamoto Y,Nara S,Kishi Y,et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?[J]. Surgery,2013,153(6):794-800.
|
[28] |
夏果毅,刘苏来,孙增鹏,等. 肝胰十二指肠切除在6例T4期胆囊癌患者治疗中的应用[J]. 中华普通外科杂志,2022,37(6):461-463.
|
[29] |
Wu X,Li M,Wu W,et al. Hepatopancreatoduodenectomy for advanced biliary malignancies[J]. Chin Med J,2022,135(23):2851-2858.
|
[30] |
Toyoda Y,Ebata T,Mizuno T,et al. Cholangiographic tumor classification for simple patient selection prior to hepatopancreatoduodenectomy for cholangiocarcinoma[J]. Ann Surg Oncol,2019,26(9):2971-2979.
|
[31] |
王健东,全志伟. 重视胆道恶性肿瘤化疗联合靶向免疫的综合治疗[J/OL]. 中华肝脏外科手术学电子杂志,2023,12(2):125-130.
|